Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1987-10-27
1991-02-26
Kepplinger, Esther L.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
424 851, 424 852, 424 858, 435 19, 435 28, 435 32, 435184, 436 63, 436501, 436548, G01N 3353, G01N 33577, C12Q 128, C12Q 118
Patent
active
049961454
ABSTRACT:
A method for detecting the sensitivity of tumor cells to immune effector substances by using an assay that distinguishes living tumor cells from dead cells in mixed populations of cells. Acquired resistance to immune effectors used in therapy may be determined and used to identify methods to circumvent such resistance using the method.
REFERENCES:
patent: 4758549 (1988-07-01), Mitsuhashi et al.
patent: 4778879 (1988-10-01), Mertelsman et al.
Weisenthal et al., Recent Results in Cancer Research, vol. 94, pp. 161-173, 1984.
Weisenthal et al., Cancer Research, vol. 43, pp. 258-264, Jan. 1983.
Weisenthal et al., Cancer Research, vol. 43, pp. 749-754, Feb. 1983.
Kimber et al., Expl. Cell. Biol., vol. 53, pp. 69-84, 1985.
Rabinowich et al., Cancer Research, vol. 47, pp. 173-177, Jan. 1987.
Endo et al., Cancer Research, vol. 47, pp. 1076-1080, Feb. 1987.
Durkin et al., Cancer Research, vol. 39, pp. 402-407, 1979.
Weisenthal et al., Cancer, vol. 51(8), Apr. 15, 1983, pp. 1490-1495.
Fahey et al., Annals of Internal Medicine, vol. 106, 1987, pp. 257-274.
Weisenthal, Seminars in Oncology, vol. 8(4), Dec. 1981 pp. 362-376.
Weisenthal et al., Clinical Investigations, AACR Abstracts, No. 614, p. 155, vol. 22(8), 1981.
Weisenthal et al., Proceedings of AACR, vol. 27, Mar. 1986, p. 393, No. 1560.
Dolan et al., Proceedings of AACR, vol. 27, Mar. 1986, p. 100, No. 394.
Gambacorit-Passerini et al., Cancer Research 47; 2547-2552 (1987), "Lysis by Activated Lymphocytes of Melanoma and Snall Cell Lung Cancer Cells Surviving in Vitro Treatment with Mafosfamide".
Weisenthal et al., Cancer Treat. Rep. 70:1283-1295 (1986), "Laboratory Detection of Primary and Acquired Drug Resistance in Human Lymphatic Neoplasms".
Weisenthal et al., Cancer Treat. Rep. 71(12): 1239-1243 (1987), "Perturbation of In Vitro Drug Resistance in Human Lymphatic Neoplasms by Combinations of Putative Inhibitors of Protein Kinase C".
Bosanquet et al., "An Assessment of a Short-Term Tumour Chemosensitivity Assay in Chronic Lymphcytic Leukaemia," Br. J. Cancer 47:781-789.
Bosanquet et al., "Short-Term Tumour Chemosensitivity Assay for Haematological Malignancies: Improved Leukocyte Identification and Comparison of Drug Sensitivities in Blood, Marrow and Lymph Node," in 13th Internatonal Congress of Chemotherapy, Spitzy et al., Eds. Verlag H. Egermann, Vienna, Part 224, pp. 130-133 (1983).
Weisenthal et al. "Clonogenic and Nonclonogenic in Vitro Chemosensitivity Assays," Cancer Treatment Rep. 69(6) 615-632 (1985).
Bird et al., "In Vitro Determination of Tumour Chemosensitivity in Haematological Malignancies," Hematological Oncology 3:1-9 (1985).
Bird et al., "The Influence of Sample Source and Cell Concentration on the In Vitro Chemosensitivity of Haematological Tumours," Br. J. Cancer 55:539-545 (1986).
Bird et al., "Semi-Micro Adaptation of a 4-Day Differential Staining Cytotoxicity (DiSC) Assay for Determining the In-Vitro Chemosensitivity of Haematological Malignancies," Leukemia Res. 10(4): 445-449 (1986).
Carmiachel et al., "Evaluation of a Tetrazolium-Based Semiautomated Colorimetric Assay: Assessment of Chemosensitivity Testing," Cancer Research 47:936-942 (1987).
Carmichael et al., "Evaluation of a Tetrazolium-Based Semiautomated Colormetric Assay: Assessment of Radiosensitivity" Cancer Research 47:943-946 (1987).
de Vries et al., "In Vitro Chemosensitivity of Human Lung Cancer for Vindesine," Eur. J. Cancer Oncol. 23:55-60 (1987).
Bird et al., "Comparison of In Vitro Drug Sensitivity by the Differential Staining Cytotoxicity (DiSC) and Colony-Forming Assays," Br. J. Cancer 55:429-431 (1987).
Su et al., "Selective Enhancement by Menadiol of In Vitro Drug Activity in Human Lymphatic Neoplasms," Cancer Treatment Rep. 71(6) 619-625 (1987).
Ruckdeschel et al., "In Vitro Chemosensitivity of Human Lung Cancer Cell Lines," Cancer Treatment Rep. 71 (7-8): 697-704 (1987).
Weisenthal et al., "Perturbation of In Vitro Drug Resistance in Human Lymphatic Neoplasms by Combinations of Putative Inhibitors of Protein Kinase C, " Cancer Treatment Rep. 71(12): 1239-1243 (1987).
Bosanquet et al., "Determination of Acquired Drug Resistance and Cross-Resistance in Haematological Malignancies" Biochem. Soc. Transactions 14:620-621 (1986).
Einhorn et al., "Interferon Exerts a Cytotoxic Effect on Primary Human Mylenoma Cells," Eur. J. Cancer Clin. Oncol. 24:1505-1510 (1988).
Weisenthal et al., "A Novel Dye Exclusion Assay for Predicting Response to Cancer Chemotherapy," Proc. Amer. Assoc. Cancer REs. 22:155.
Weisenthal et al., "Comparison of 3 In-Vitro Chemosensitivity Assays: Dye Exclusion (DE), Autoradiography (AR), and Agar Cloning (AC), " Proc. Amer. Assoc. Cancer Res. 23:184 (Abstr. 723) (1982).
Bosanquet et al., "A Four-Day Method in Vitro for the Prediction of Response to Cytotoxic Drugs in Chronic Lympuocytic Leukaemia and Other Tumors " Biochem Soc. Trans. 10:505-506 (abstr.) (1982).
Bosanquet et al., "In Vitro Chemosensitivity in Haematological Tumors (HT)", Proc. Amer. Assoc. Cancer Res. 26:362 (Abstr. 1428) (1985).
Ruckdeschel et al., "The Use of Human Lung Cancer Cell Lines for In Vitro Chemosensitivity Testing", Proc. Amer. Assoc. Cancer Res. 26:367 (Abstr. 1449) (1985).
Ihde et al., "Feasibility of In Vitro Growth and Chemosensitivity Testing (CT) of Small Cell Lung Cancer (SCLC) Cells in a Prospective Clinical Trial," Proc. Amer. Assoc. Cancer Res. 26:369 (Abstr. 1456) (1985).
Weisenthal et al., "Clinical Correlations (CC) of Chemosensitivity (CS) with a Predictive Dye Esxclusioin Assay (DEA) in Human Lymphatic Neoplasms (LN)," Proc. Amer. Assoc. Cancer REs. 26:369 (Abstr. 1457) (1985).
Carmichael et al., "Comparison of Clonogenic and Non Clonogenic Assays in the Assessment of Drug and Radiation Sensitivity," Proc. Amer. Soc. Clinical Oncol. 5:176 (Abstr. 65) (1986).
Fine et al., "Increased Phosphorylation of a 20 kD Protein is Associated with Pleiotropic Drug Resistance (PDR) in Human Small-Cell Lung Cancer (SCLC) Line," Proc. Amer. Soc. Clinical Oncol. 5:17 (Abstr. 68) (1986).
Gazdar et al., "Drug Sensitivity Testing (DST) Patterns of Small Cell Lung Cancer (SCLC) Cultures: Correlation with Clinical Response," Proc. Amer. Soc. Clinical On col. 5:179 (Abstr. 700) (1986).
Wilbur et al., "Chemosensitivity Guided Chemotherapy of Non-Small Cell Lung Carcinoma. Updating a Pilot Study Using a Dye Exclusion Assay," Proc. Amer. Soc. Clinical Oncol. 5:179 (Abstr. 703) (1986).
Weisenthal et al., "Laboratory Detection and Circumvention of Drug Resistance (DR) in Hyman Lymphatic Neoplasms (LN)", Proc. Amer. Assoc. Cancer Res. 27:393 (Abstr. 1560) (1986).
Hoffer Florina B.
Kepplinger Esther L.
Oncotech Incorporated
LandOfFree
Method for detecting immune-mediated cytotoxicity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detecting immune-mediated cytotoxicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detecting immune-mediated cytotoxicity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-293659